Y. Le Roux

541 total citations
15 papers, 453 citations indexed

About

Y. Le Roux is a scholar working on Pharmacology, Psychiatry and Mental health and Analytical Chemistry. According to data from OpenAlex, Y. Le Roux has authored 15 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 3 papers in Analytical Chemistry. Recurrent topics in Y. Le Roux's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Epilepsy research and treatment (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Y. Le Roux is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Epilepsy research and treatment (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Y. Le Roux collaborates with scholars based in France, Austria and United States. Y. Le Roux's co-authors include Armand Frydman, J.J. Thebault, F. Collignon, Henri Caplain, J. Bouthier, Guy Montay, J. Gaillot, A. Le Liboux, Stéphane Kirkesseli and Philippe Truffinet and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, SLEEP and Journal of Pharmaceutical Sciences.

In The Last Decade

Y. Le Roux

14 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y. Le Roux France	10	143	127	125	92	78	15	453
A. Le Liboux France	12	156 1.1×	148 1.2×	115 0.9×	90 1.0×	35 0.4×	18	613
David Case United States	13	100 0.7×	11 0.1×	33 0.3×	23 0.3×	53 0.7×	39	460
Adam Sokal Poland	17	14 0.1×	546 4.3×	42 0.3×	115 1.3×	40 0.5×	74	807
Kasra Shakeri‐Nejad Switzerland	10	34 0.2×	131 1.0×	91 0.7×	21 0.2×	42 0.5×	22	374
Kerryn L. Simpson New Zealand	10	67 0.5×	117 0.9×	27 0.2×	70 0.8×	108 1.4×	10	571
DOROTHY BUSFIELD United States	10	44 0.3×	73 0.6×	10 0.1×	44 0.5×	29 0.4×	13	426
Cheryl Mahony United States	11	32 0.2×	185 1.5×	43 0.3×	79 0.9×	22 0.3×	18	379
Vijay Ivaturi United States	16	119 0.8×	83 0.7×	4 0.0×	111 1.2×	82 1.1×	51	788
Jane K. McGavin New Zealand	10	46 0.3×	62 0.5×	14 0.1×	58 0.6×	115 1.5×	11	577
Elena Tremoli Italy	11	27 0.2×	84 0.7×	33 0.3×	46 0.5×	90 1.2×	26	556

Countries citing papers authored by Y. Le Roux

Since Specialization

Citations

This map shows the geographic impact of Y. Le Roux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Le Roux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Le Roux more than expected).

Fields of papers citing papers by Y. Le Roux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Le Roux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Le Roux. The network helps show where Y. Le Roux may publish in the future.

Co-authorship network of co-authors of Y. Le Roux

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Le Roux. A scholar is included among the top collaborators of Y. Le Roux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Le Roux. Y. Le Roux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Roux, Y. Le, et al.. (1998). Use of the repeated cross-over design in assessing bioequivalence: (within and between subjects variability — Schuirmann Confidence Intervals estimation). European Journal of Drug Metabolism and Pharmacokinetics. 23(2). 339–345. 2 indexed citations

Liboux, A. Le, et al.. (1997). Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects. The Journal of Clinical Pharmacology. 37(9). 820–827. 68 indexed citations

Roux, Y. Le, et al.. (1995). Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System. Clinical Drug Investigation. 10(3). 172–178. 21 indexed citations

Collignon, F., Armand Frydman, Henri Caplain, et al.. (1995). Comparison of the Pharmacokinetic Profiles of Three Low Molecular Mass Heparins – Dalteparin, Enoxaparin and Nadroparin – Administered Subcutaneously in Healthy Volunteers (Doses for Prevention of Thromboembolism). Thrombosis and Haemostasis. 73(4). 630–640. 150 indexed citations

Bernard, E, et al.. (1994). Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476). European Journal of Clinical Microbiology & Infectious Diseases. 13(9). 768–771. 9 indexed citations

Montay, Guy, René Bruno, J. Vergniol, et al.. (1994). Pharmacokinetics of Sparfloxacin in Humans After Single Oral Administration at Doses of 200, 400, 600, and 800 mg. The Journal of Clinical Pharmacology. 34(11). 1071–1076. 34 indexed citations

Fillastre, J P, Guy Montay, René Bruno, et al.. (1994). Pharmacokinetics of sparfloxacin in patients with renal impairment. Antimicrobial Agents and Chemotherapy. 38(4). 733–737. 19 indexed citations

Bruno, René, Bruno Lacarelle, Valérie Cosson, et al.. (1992). Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: Application to pefloxacin in intensive care unit patients. Journal of Pharmacokinetics and Biopharmaceutics. 20(6). 653–669. 25 indexed citations

Montay, Guy, Y. Le Roux, A. Le Liboux, et al.. (1991). Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution. Drugs. 42(Supplement 4). 6–9. 11 indexed citations

10.

Frydman, Armand, Y. Le Roux, J. F. Desnottes, et al.. (1988). Pharmacokinetics of spiramycin in man. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 93–103. 25 indexed citations

11.

Gaillot, J., Y. Le Roux, G. W. Houghton, & Jean‐François Dreyfus. (1987). Critical Factors for Pharmacokinetics of Zopiclone in the Elderly and in Patients with Liver and Renal Insufficiency. SLEEP. 10 Suppl 1. 7–21. 22 indexed citations

12.

Frydman, Armand, et al.. (1986). Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers. Journal of Antimicrobial Chemotherapy. 17(suppl B). 65–79. 55 indexed citations

13.

Roux, Y. Le, et al.. (1982). High-performance liquid chromatographic determination of pipotiazine in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 230(2). 401–408. 4 indexed citations

14.

Hirtz, J, et al.. (1979). Clinical pharmacology studies with acenocoumarol.. PubMed. 17(8). 361–5. 1 indexed citations

15.

Roux, Y. Le, et al.. (1977). Determination of Acenocoumarol in Plasma and Urine by Double Radioisotope Derivative Analysis. Journal of Pharmaceutical Sciences. 66(7). 997–1000. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact